A new synthesis of 2’-deoxypuromycin (18) as well as its α-anomer 17 is described. Reaction of 1,5-di-O-acetyl-2,3-dideoxy-3-phthalimido-β-D-erythro-pentofuranose (3) with silylated 6-dimethylaminopurine using trimethylsilyl trifluoromethanesulfonate as catalyst afforded the α and β nucleosides 7 and 12 in 15 and 25% yield, respectively. After deblocking of both amino and hydroxy groups with methylamine in ethanol, the nucleosides were condensed with Fmoc-4-O-methyl-L-tyrosine and subsequently deprotected to give the target compounds 17 and 18. Compound 3 is converted into its glycosyl bromide 4 in quantitative yield on treatment with trimethylsilyl bromide, and reacted with the sodium salt of 6-dimethylaminopurine to give the corresponding protected N-7 and N-9 α glycosyl nucleosides 7 and 8 in 34 and 39% yield, respectively. The 2’-deoxypuromycin is inactive against HIV-1 in MT-4 cells.
本文描述了 2'-deoxypuromycin (18) 及其 δ-anomer 17 的新合成方法。以
三氟甲磺酸三甲基硅酯为催化剂,将 1,5-二-O-乙酰基-2,3-二脱氧-3-邻苯二甲酰亚
氨基-δ-D-赤式戊
呋喃糖 (3) 与
硅烷化的
6-二甲基氨基嘌呤反应,得到了δ和δ核苷 7 和 12,产率分别为 15% 和 25%。在
乙醇中用
甲胺脱锁
氨基和羟基后,核苷与 Fmoc-4-O-methyl-L-tyrosine 缩合,随后脱保护,得到目标化合物 17 和 18。化合物 3 经三甲
硅基
溴化物处理后定量转化为其糖基
溴化物 4,并与 6-
二甲氨基嘌呤钠盐反应,得到相应的受保护 N-7 和 N-9 δ糖基核苷 7 和 8,收率分别为 34% 和 39%。2'-deoxypuromycin 对
MT-4 细胞中的 HIV-1 无活性。